← Eichor
Condition: Growth Disorder Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Growth Disorder

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Placental Progesterone Membrane Receptors in Fetal Growth Restriction
Phase N/A · 1 location(s) · Samsun University · NCT07701837Natural History of Craniofacial Anomalies and Developmental Growth Variants
Phase N/A · 1 location(s) · National Institute of Dental and Craniofacial Research (NIDC · NCT02639312Developing and Testing the Effectiveness of a Skin Cancer Self-Detection Educational Program
NA · 1 location(s) · National University Hospital, Singapore · NCT07247123Feasibility of Remote eCTG Monitoring Home@Hospital in Complicated Pregnancies
NA · 1 location(s) · Maxima Medical Center · NCT06859177Trastuzumab Emtansine(T-DM1) After Trastuzumab Deruxtecan(T-DXd) in HER2-Positive Breast Cancer in Korea
Phase N/A · 1 location(s) · Seoul National University Hospital · NCT06928818A Study of BL-B01D1 and Almonertinib in Patients With Resectable EGFR+ Stage II-IIIB NSCLC
Phase 2 · 1 location(s) · Sichuan University · NCT06951464KETOgenic Diet Therapy in Patients With ACROmegaly
NA · 1 location(s) · Erasmus Medical Center · NCT06949891Maternal Characteristics Associated With Child Growth and Adiposity
Phase N/A · 1 location(s) · Instituto de Desarrollo e Investigaciones Pediátricas Prof. · NCT05798676Study to Assess GTAEXS617 in Participants With Advanced Solid Tumors
Phase 1/Phase 2 · 13 location(s) · Exscientia AI Ltd., a wholly owned subsidiary of Recursion P · NCT05985655Targeted Fortification of Donor Breast Milk in Preterm Infants
NA · 1 location(s) · Columbia University · NCT04294368Impact of Early Fortini Initiation on Growth and Interstage Outcomes in Infants With Single Ventricle Physiology
NA · 1 location(s) · Driscoll Children's Hospital · NCT07087782A Study Evaluating Adherence, Tolerability, and Patient Reported Outcomes of Giredestrant in Participants With ER+/HER2-
Phase 3 · 1 location(s) · Genentech, Inc. · NCT07541079Assessing the Efficacy and Safety of Anti-HER2 Therapy in Nigerian Women With HER2+ Breast Cancer Before and After Surge
Phase 2 · 4 location(s) · University of Chicago · NCT06348134Optimizing Early Nutrition Management of Extremely and/or Very Preterm Infants
NA · 1 location(s) · Children's Hospital of Fudan University · NCT07538999Efficacy and Safety of Intranasal Cenegermin in Adult Participants With Non-Arteritic Anterior Ischemic Optic Neuropathy
Phase 3 · 18 location(s) · Dompé Farmaceutici S.p.A · NCT07453888Genetic, Metabolic, and Growth Factor Repository for Cerebrovascular Disorders
Phase N/A · 1 location(s) · Cedars-Sinai Medical Center · NCT02910180Fibroblast Growth Factor 23 and Risk of Cardiac Arrhythmias in Hemodialysis Patients
Phase N/A · 1 location(s) · Antonio Bellasi · NCT06668831PIERS and BIS, sFIT:PIGF, Adrenomedullin
Phase N/A · 1 location(s) · Suez Canal University · NCT02578810Neuropsychological Assessment of Children and Adolescents With Turner Syndrome
Phase N/A · 3 location(s) · University Hospital, Angers · NCT03812913Growth Hormone Resistance of Beta-cells A
Phase N/A · 1 location(s) · University of Missouri-Columbia · NCT06571487To Investigate the Effects of Bifidobacterium Animalis Subsp. Lactis XLTG11 on Growth and Development, Incidence of Alle
Phase 2 · 2 location(s) · Min-Tze LIONG · NCT07490587Efficacy and Safety of Add-on Timolol for EGFR-TKI and ALK-TKI Induced Paronychia
Phase 3 · 1 location(s) · Queen Mary Hospital, Hong Kong · NCT06643416SeOuL cOhort of Brain Tumor MONitoring Study (SOLOMON)
Phase N/A · 1 location(s) · Seoul National University Hospital · NCT05254197Feeding Tolerance and Growth of Preterm Infants Consuming a Supplement Containing Two Human Milk Oligosaccharides (HMOs)
NA · 6 location(s) · Société des Produits Nestlé (SPN) · NCT06212427Sacituzumab Govitecan and Intrathecal Chemotherapy for Treating Leptomeningeal Metastases From Her2-negative Breast Canc
Phase 1/Phase 2 · 1 location(s) · Guangzhou Medical University · NCT06462092Effects of Pasireotide Lar Therapy on Bone Metabolism
Phase N/A · 1 location(s) · Fondazione Policlinico Universitario Agostino Gemelli IRCCS · NCT07179926A Study to Evaluate the Effect of GDC-4198 Alone and in Combination With Giredestrant Versus Abemaciclib and Giredestran
Phase 1/Phase 2 · 52 location(s) · Genentech, Inc. · NCT07100106Functional and Morphological Characterization of Multiple Osteochondromas Disorder
Phase N/A · 1 location(s) · Istituto Ortopedico Rizzoli · NCT06703736Zanzalintinib (XL-092) Plus Durvalumab and Tremelimumab in Unresectable Hepatocellular Carcinoma (ZENOBIA)
Phase 2 · 3 location(s) · Anwaar Saeed · NCT06698250JS212 Plus JS111 in EGFR-Mutant Advanced NSCLC: A Phase II Study
Phase 2 · 2 location(s) · Shanghai Junshi Bioscience Co., Ltd. · NCT07518160
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.